First Interstate Bank’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,025
Closed -$154K 715
2017
Q3
$154K Buy
2,025
+1,508
+292% +$112K 0.03% 211
2017
Q2
$49K Hold
517
0.01% 350
2017
Q1
$41K Sell
517
-541
-51% -$43.1K 0.01% 366
2016
Q4
$88K Sell
1,058
-134
-11% -$12.1K 0.02% 281
2016
Q3
$133K Buy
1,192
+884
+287% +$97.7K 0.03% 238
2016
Q2
$34K Buy
+308
New +$37.4K 0.01% 388

Other funds holding INO

First Interstate Bank's INO Position: Q4 2017 in Review

First Interstate Bank sold out of Inovio Pharmaceuticals (INO) in Q4 2017, closing a stake of 2,025 shares — an estimated $154K sold.

First Interstate Bank first reported a position in INO in Q2 2016 and held it in 6 quarters. The position peaked at $154K in Q3 2017. 133 funds tracked by Wall St. Rank hold INO as of Q4 2017.

  • First Interstate Bank reported no remaining Inovio Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • First Interstate Bank sold 2,025 Inovio Pharmaceuticals shares in Q4 2017, an estimated $154K.
  • First Interstate Bank first reported a position in Inovio Pharmaceuticals in Q2 2016 and held it in 6 quarters.
  • First Interstate Bank's Inovio Pharmaceuticals position peaked at $154K in Q3 2017.
  • 133 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2017.

Based on First Interstate Bank's 13F filing for Q4 2017, filed 13 Feb 2018.